Why the study?
What is the current practice of consultant otolaryngologists regarding DVT prophylaxis in patients undergoing head and neck cancer surgery?
What is the current practice of consultant otolaryngologists regarding DVT prophylaxis in patients undergoing head and neck cancer surgery?
There is a lack of consensus and significant variation in the use of DVT prophylaxis among otolaryngologists for head and neck cancer surgery patients.
Answers are grounded in this paper and cite their sources.
DVT prophylaxis use varies widely among otolaryngologists; leaves open the optimal strategy pending prospective trials.
Deep venous thrombosis (DVT) and pulmonary embolism (PE) are an important cause of morbidity and mortality in the surgical patient. The first guideline produced by the Scottish Intercollegiate Guidelines Network was for the prophylaxis of venous thromboembolism. Patients undergoing major head and neck cancer surgery commonly exhibit risk factors for venous thromboembolism. Currently, however, there are no data on its incidence in these patients. A questionnaire survey was performed to assess the current practice of consultant otolaryngologists regarding DVT prophylaxis in patients undergoing head and neck cancer surgery. Of those respondents who managed these patients, 57 per cent did not use routine DVT prophylaxis while 43 per cent did. A wide variety of techniques were employed among those practising DVT prophylaxis. A consensus is needed concerning the use of thromboembolism prophylaxis in head and neck surgery patients.
No takes yet. Share an insight, caveat, or question.
Ah-See et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: